Obesity and kidney disease in type 1 and 2 diabetes: An analysis of the National Diabetes Audit

QJM: An International Journal of Medicine

Volumn 106, Issue 10, 2013, Pages 933-942

  Hill, C J ^a,b   Cardwell, C R ^a   Maxwell, A P ^a,b   Young, R J ^c   Matthews, B ^d   O'Donoghue, D J ^e   Fogarty, D G ^a,b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^d New Croft House   (United Kingdom)

^e Department of Health ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C;

ADULT; ALBUMINURIA; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; GREAT BRITAIN; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84884726412     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hct123     Document Type: Article

References (37)

1. Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006; 12:62-6.
2. DeFronzo RA. Insulin secretion, insulin resistance, and obesity. Int J Obes 1982; 6(Suppl. 1):73-82.
3. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14:173-94.
4. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59:1498-509.
5. Wuerzner G, Pruijm M, Maillard M, Bovet P, Renaud C, Burnier M, et al. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis 2010; 56:303-12.
6. Chen HM, Liu ZH, Zeng CH, Li SJ, Wang QW, Li LS. Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis 2006; 48:772-9.
7. Ferris M, Hogan SL, Chin H, Shoham DA, Gipson DS, Gibson K, et al. Obesity, albuminuria, and urinalysis findings in US young adults from the Add Health Wave III study. Clin J Am Soc Nephrol 2007; 2:1207-14.
8. Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, et al. Overweight, obesity, and the development of stage 3 CKD: The Framingham Heart Study. Am J Kidney Dis 2008; 52:39-48.
9. Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2009; 4:1565-74.
10. Harjutsalo V, Katoh S, Sarti C, Tajima N, Tuomilehto J. Population-based assessment of familial clustering of diabetic nephropathy in type 1 diabetes. Diabetes 2004; 53:2449-54.
11. Thorn LM, Kilpikari R, Forsblom C, Groop PH, Fagerudd J, Pettersson-Fernholm K. on behalf of the FinnDiane Study Group. Clustering of risk factors in parents of patients with type 1 diabetes and nephropathy. Diabetes Care 2007; 30:1162-7.
12. Hadjadj S, Duengler F, Torremocha F, Faure-Gerard G, Bridoux F, Boissonnot M, et al. Maternal history of type 2 diabetes is associated with diabetic nephropathy in type 1 diabetic patients. Diabetes Metab 2007; 33:37-43.
13. Reddy MA, Natarajan R. Epigenetics in diabetic kidney disease. J Am Soc Nephrol 2011; 22:2182-5.
14. Williams ED, Tapp RJ, Magliano DJ, Shaw JE, Zimmet PZ, Oldenburg BF. Health behaviours, socioeconomic status and diabetes incidence: the Australian Diabetes Obesity and Lifestyle Study (AusDiab). Diabetologia 2010; 53:2538-45.
15. Maty SC, James SA, Kaplan GA. Life-course socioeconomic position and incidence of diabetes mellitus among blacks and whites: the Alameda County Study, 1965-1999. Am J Public Health 2010; 100:137-45.
16. National Diabetes Audit. The Information Centre for Health and Social Care, NHS, 2013. http://www.ic.nhs.uk/nda (31 March 2013, date last accessed).
17. Levey AS, Stevens LA, Schmid CH, Zhang YP, Castro AF, Feldman HI, et al. on behalf of the Chronic Kidney Disease Epidemiology Collaboration. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-12.
18. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. on behalf of the Chronic Kidney Disease Epidemiology Collaboration. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53:766-72.
19. Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, et al. on behalf of the Chronic Kidney Disease Prognosis Consortium. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 2012; 308:1-12.
20. Conway B, Miller RG, Costacou T, Fried L, Kelsey S, Evans RW, et al. Temporal patterns in overweight and obesity in type 1 diabetes. Diabet Med 2010; 27:398-404.
21. de Boer IH, Sun WJ, Cleary PA, Lachin JM, Molitch ME, Steffes MW, et al. on behalf of the DCCT/EDIC Research Group. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 2011; 365:2366-76.
22. World Health Organisation Global Health Observatory. http://www.who.int/gho/ncd/risk_factors/obesity_text/en (30 April 2013, date last accessed).
23. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012; 307:483-90.
24. Priou P, Hamel JF, Person C, Meslier N, Racineux JL, Urban T, et al. Long-term outcome of noninvasive positive pressure ventilation for obesity hypoventilation syndrome. Chest 2010; 138:84-90.
25. Seidell JC, Verschuren WMM, vanLeer EM, Kromhout D. Overweight, underweight, and mortality-a prospective study of 48287 men and women. Arch Intern Med 1996; 156:958-63.
26. Luk AOY, So WY, Ma RCW, Kong APS, Ozaki R, Ng VSW, et al. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care 2008; 31:2357-61.
27. Mohsen A, Brown R, Hoefield R, Kalra PA, O'Donoghue D, Middleton R, et al. Body mass index has no effect on rate of Obesity and kidney disease in type 1 and 2 diabetes 941 progression of chronic kidney disease in subjects with type 2 diabetes mellitus. J Nephrol 2012; 25:384-93.
28. de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, Cleary PA, et al. Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol 2007; 18:235-43.
29. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a metaanalysis among different ethnic groups. Int J Obesity 1998; 22:1164-71.
30. Barba C, Cavalli-Sforza T, Cutter J, Darnton-Hill I, Deurenberg P, Deurenberg-Yap M, et al. Appropriate bodymass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363:157-63.
31. Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care 2011; 34:1741-8.
32. Lear SA, Humphries KH, Kohli S, Birmingham CL. The use of BMI and waist circumference as surrogates of body fat differs by ethnicity. Obesity 2007; 15:2817-24.
33. Lear SA, Kohli S, Bondy GP, Tchernof A, Sniderman AD. Ethnic variation in fat and lean body mass and the association with insulin resistance. J Clin Endocrinol Metab 2009; 94:4696-702.
34. Razak F, Anand SS, Shannon H, Vukshan V, Davis B, Jacobs R, et al. Defining obesity cut points in a multiethnic population. Circulation 2007; 115:2111-8.
35. National Institute for Health and Clinical Excellence. Hypertension: Clinical Management of Hypertension in Adults (CG127). London, National Institute for Health and Clinical Excellence, 2011.
36. Coresh J, Selvin E, Stevens LA, Manzi J, Kusk JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298:2038-47.
37. Delorenzo A, Barra PFA, Sasso GF, Battistini NC, Duerenberg P. Body impedance measurements during dialysis. Eur J Clin Nutr 1991; 45:321-5.